Orthofix Medical Inc. Deferred Revenue Recognized
Orthofix Medical Inc. (OFIX) reported Deferred Revenue Recognized of $2.20 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-25.
Financial Statements › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2025-02-25
- Orthofix Medical Inc. contract with customer, liability, revenue recognized for the quarter ending 2023-03-31 was $2.20M.
- Orthofix Medical Inc. contract with customer, liability, revenue recognized for fiscal 2024 was $2.20M, a 0.00% change from fiscal 2023.
- Orthofix Medical Inc. contract with customer, liability, revenue recognized for fiscal 2023 was $2.20M.
| Period end | Contract with Customer, Liability, Revenue Recognized 3 month | Contract with Customer, Liability, Revenue Recognized 6 month | Contract with Customer, Liability, Revenue Recognized 9 month | Contract with Customer, Liability, Revenue Recognized 12 month |
|---|---|---|---|---|
| 2024-12-31 | $2.20M 10-K · filed 2025-02-25 | |||
| 2023-12-31 | $2.20M 10-K · filed 2024-03-05 | |||
| 2023-09-30 | $2.20M 10-Q · filed 2023-11-08 | |||
| 2023-06-30 | $2.20M 10-Q · filed 2023-08-08 | |||
| 2023-03-31 | $2.20M 10-Q · filed 2023-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |